Shree Pacetronix Limited has received formal trading approval from BSE Limited for 75,150 equity shares issued to promoters on a preferential basis. The approval, effective from January 22, 2026, marks a significant corporate development for the cardiac pacing technology company.

Share Issuance Details

The approved equity shares carry specific financial and technical parameters that define the preferential allotment structure.

The total value of the preferential allotment amounts to ₹60.87 crores, calculated at the issue price of ₹81.00 per share. This represents a premium of 710% over the face value, indicating strong confidence in the company's prospects.

Regulatory Compliance and Approval Process

The trading approval was granted under strict regulatory compliance with SEBI Listing Regulations. BSE Limited issued the approval letter on January 21, 2026, with reference number LOD/PREF/PB/249/2025-2026. The exchange confirmed that the securities are listed effective from January 22, 2026.

Shree Pacetronix Limited has fulfilled all necessary regulatory requirements under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's compliance was overseen by Company Secretary Rupali Ahire, who digitally signed the regulatory intimation.

Company Background and Operations

Shree Pacetronix Limited operates as a specialized medical technology company focusing on cardiac pacing solutions. The company is currently celebrating 25 years of operations in the cardiac pacing industry, demonstrating its established presence in the healthcare technology sector.

The company maintains multiple operational locations across India, including its registered office and factory in Pithampur, Madhya Pradesh, along with offices in Bangalore and Kolkata. Shree Pacetronix Limited holds several quality certifications including ISO 13485 and ISO 9001, reflecting its commitment to medical device manufacturing standards.

Market Implications

The successful completion of the preferential allotment process and receipt of trading approval demonstrates the company's ability to execute capital raising initiatives effectively. The preferential shares are now available for trading on BSE Limited, providing liquidity options for the promoter while maintaining compliance with all regulatory requirements.

BSE Limited has issued Notice No. 20260121-20 dated January 21, 2026, to inform trading members about the listing of these securities. This formal notification ensures market participants are aware of the new shares available for trading.

Shree Pacetronix Ltd has received a substantial acquisition disclosure from Dheeraj Kumar Lohia under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure reveals an increase in shareholding through open market purchase of equity shares on January 5, 2026.

Acquisition Details

Dheeraj Kumar Lohia acquired 18,400 shares of Shree Pacetronix Ltd through open market transactions, representing 0.47% of the company's total share capital. The acquisition was completed on January 5, 2026, as per the regulatory filing dated January 7, 2026.

Shareholding Pattern Changes

The acquisition resulted in a notable change in Lohia's shareholding pattern in the company. Prior to this transaction, his holding stood at 186,662 shares, representing 4.78% of the total equity.

Acquirer Profile and Associated Entities

The disclosure identifies Dheeraj Kumar Lohia as the primary acquirer, who does not belong to the promoter or promoter group of Shree Pacetronix Ltd. The filing also lists persons acting in concert (PAC) with the acquirer:

• Dheeraj Kumar Lohia (HUF)
• Mrs. Sonal Lohia
• Rajkumar Lohia (HUF)
• Mr. Rajkumar Lohia

Company Information

Shree Pacetronix Ltd's shares are listed on the BSE (Bombay Stock Exchange). The company maintains an equity share capital of 39,00,000 shares of ₹10.00 each, which remained unchanged before and after the acquisition. The total diluted share capital also stands at the same level, indicating no outstanding convertible securities or warrants.

Regulatory Compliance

This disclosure fulfills the mandatory reporting requirements under SEBI regulations for substantial acquisitions. The filing was submitted from Ghaziabad and demonstrates compliance with transparency norms for shareholding changes exceeding the prescribed thresholds in publicly listed companies.